Home

SCHEER Preliminary Guidelines on the Presence of Phthalates in Certain Medical Devices: Public Hearing, 4 April 2019, Brussels (05 Februar 2019)

At the request of the European Commission, the preliminary guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices are covering phthalates, which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties. Deadline for registration: 6 March 2019.

Commission publishes Statement and Position Paper on Emerging Health and Environmental Issues (14 Januar 2019)

The Statement and Position Paper are published by the Commission’s Scientific Committee on Health, Environmental and Emerging Risks (SCHEER).

Health-EU Newsletter: Special Edition - Scientific Committees (10 Januar 2019)

by Prof Peter Hoet, member of the Scientific Committee on Environmental and Emerging Risks (SCHEER) and Chair of the SCHEER Working Group on oil and gas, Medical Faculty, Katholieke Universiteit Leuven, Belgium.

New infographic on Weight of Evidence (29 November 2018)

This infographic explains and visualizes the Weight of Evidence process as applied by the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER)

SCCS Notes of Guidance - 10th revision (15 November 2018)

New factsheet highlighting the changes made in this new version of the SCCS Notes of Guidance for the testing of cosmetic ingredients and their safety evaluation

Select your language

EU's sundhedspolitik

Improving health systems

Et godt helbred

Lægemidler

Indsats mod sygdomme

Risikovurdering

Endocrine disruptors

Biocides

test title

/health/file/sccs_buttonjpg_dasccs_button.jpg

/health/file/scheer_buttonjpg_dascheer_button.jpg

/health/file/database_expertsjpg_dadatabase_experts.jpg

/health/file/laymanjpg_dalayman.jpg

/health/file/scientific_journalsjpg_dascientific_journals.jpg

/health/file/newsletterjpg_danewsletter.jpg

/health/file/linksjpg_dalinks.jpg